文献速递重症综合管理与镇静镇痛心脑血管急症复苏、休克与脓毒症

基于无创脑自动调节的重症患者个体化平均动脉压目标:范围综述

Individualized mean arterial pressure targets in critically ill patients guided by non-invasive cerebral-autoregulation: a scoping review.
PubMed 文献 · Crit Care · 2025-05-16
一句话结论范围综述提示重症患者个体化MAP目标变异大,仅心脏外科等少数人群有数据,缺乏其他亚组观察性研究与高质量RCT。

当前指南推荐重症患者统一MAP目标(如脓毒症和心脏骤停后65 mmHg),但脑自动调节能力可能因人而异。本范围综述按PRISMA-ScR系统检索Ovid MedLine、Embase和Cochrane Library(2023年9月28日),纳入49项研究,其中45项(92%)为观察性研究、4项(8%)为干预性研究。患者人群以心脏外科(26项,53%)为主,最佳MAP报告于24项(49%)、自动调节下限于23项(47%)、上限于10项(20%);34项研究报告因软件故障、数据异常、自然MAP波动不足和工作流程障碍导致部分数据丢失。个体化MAP目标与急性肾损伤及主要发病率和死亡率关联最显著且一致。

要点

  • 49项研究中45项(92%)为观察性、4项(8%)为干预性,心脏外科人群占26项(53%),其他重症亚组数据有限。
  • 最佳MAP在24项(49%)研究中报告,自动调节下限在23项(47%),上限在10项(20%)。
  • 34项研究报告因软件故障、数据异常、自然MAP波动不足和工作流程障碍导致部分数据丢失。
  • 个体化MAP目标与急性肾损伤及主要发病率和死亡率关联最显著且一致。
  • 现有RCT发现维持患者处于目标范围内存在挑战。

适用人群与场景

  • 心脏外科患者(26项,53%)
  • 非心脏大手术患者(4项,8%)
  • 心脏骤停患者(8项,16%)
  • 脑损伤患者(7项,14%)
  • 呼吸衰竭和休克患者(3项,6%)
  • 脓毒症患者(3项,6%)

研究设计与关键结果

  • 范围综述按PRISMA-ScR指南系统检索Ovid MedLine、Embase(Ovid)和Cochrane Library(Wiley),检索日期为2023年9月28日,由两名独立评审员筛选标题、摘要和全文。
  • 共识别7738项研究,49项符合纳入标准;45项(92%)为观察性研究,4项(8%)为干预性研究。
  • 最佳MAP在24项(49%)研究中报告,自动调节下限在23项(47%),自动调节上限在10项(20%)。
  • 34项研究报告因软件故障、数据异常、自然MAP波动不足和工作流程障碍导致部分数据丢失。
  • 现有RCT发现维持患者处于目标范围内存在挑战。
  • 个体化MAP目标与急性肾损伤及主要发病率和死亡率关联最显著且一致。
  • 10项研究探讨人口学预测因素,仅识别出少数个体化目标的预测因素。

证据类型、等级与局限

  • 证据类型:范围综述(scoping review),按PRISMA-ScR指南进行。
  • 纳入研究中45项(92%)为观察性研究,4项(8%)为干预性研究。
  • 局限:缺乏心脏外科以外重症亚组的观察性研究,以及缺乏设计良好的RCT;原文指出解决已识别的可行性障碍可能对成功开展未来研究至关重要。

对床旁实践的改变

  • 当前指南推荐重症患者统一MAP目标(如脓毒症和心脏骤停后65 mmHg),但脑自动调节能力可能因人而异,统一目标可能不足以维持脑灌注。
  • 基于无创脑自动调节测定(如近红外光谱和经颅多普勒超声)的个体化MAP目标可能优化灌注并减少并发症。
  • 现有RCT发现维持患者处于个体化目标范围内存在挑战。
  • 个体化MAP目标与急性肾损伤及主要发病率和死亡率关联最显著且一致。
  • 作者认为解决已识别的可行性障碍可能对成功开展未来研究至关重要。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Current guidelines recommend a uniform mean arterial pressure (MAP) target for resuscitating critically ill patients; for example, 65 mmHg for patients with sepsis and post-cardiac arrest. However, since cerebral autoregulation capacity likely varies widely in patients, uniform target may be insufficient in maintaining cerebral perfusion. Personalized MAP targets, based on a non-invasive determination of cerebral autoregulation, may optimize perfusion and reduce complications.

OBJECTIVES: This scoping review summarizes the numerical values, feasibility, and clinical data on personalized MAP targets in critically ill patients. The focus is on non-invasive monitoring, such as near-infrared spectroscopy and transcranial doppler ultrasound, due to their safety, practicality and applicability to patients with- and without brain injury.

METHODS: Following PRISMA-ScR guidelines, a systematic search of Ovid MedLine, Embase (Ovid), and the Cochrane Library (Wiley) was conducted on September 28, 2023. Two independent reviewers screened titles, abstracts, and full texts for eligibility and manually reviewed references.

RESULTS: Of 7,738 studies were identified, 49 met the inclusion criteria. Of these, 45 (92%) were observational and 4 (8%) were interventional. Patient populations included cardiac surgery (26, 53%), non-cardiac major surgery (4, 8%), cardiac arrest (8, 16%), brain injury (7, 14%), respiratory failure and shock (3, 6%), and sepsis (3, 6%). Optimal MAP was reported in 24 (49%), lower limit of autoregulation in 23 (47%), and upper limit of autoregulation in 10 studies (20%). Thirty-four studies reported partial data loss due to software failures, anomalous data, insufficient natural MAP fluctuation, and workflow barriers. Available randomized controlled trials (RCT) identified challenges with maintaining patients within their target range. Studies explored the associations between personalized MAP targets and a wide range of neurological and non-neurological outcomes, with the most significant and consistent associations identified for acute kidney injury and major morbidity and mortality. Ten studies investigated demographic predictors identifying only few predictors of personalized targets.

CONCLUSION: Preliminary investigations suggest considerable variability in personalized MAP targets, which may explain differences in clinical outcomes among critically ill populations. Key gaps remain, including a lack of observational studies in critically ill subpopulations other than cardiac surgery and well-designed RCTs. Resolving identified feasibility barriers might be crucial to successfully carrying out future studies.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Xie J, Carbonara AR, Al-Battashi AW, et al. Individualized mean arterial pressure targets in critically ill patients guided by non-invasive cerebral-autoregulation: a scoping review. Crit Care. 2025. PMID: 40380314. doi:10.1186/s13054-025-05432-5

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。